Evidence map›Paper›PMID 39717277›Full record

ArticleFrontiers in microbiology2024

The impact of zinc pre-exposure on ciprofloxacin resistance development in

Mark P Suprenant, Carly Ching, Neila Gross, Indorica Sutradhar, Jessica E Anderson, Nourhan El Sherif, Muhammad H Zaman

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark P SuprenantDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Carly ChingDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Neila GrossDepartment of Materials Science and Engineering, Boston University, Boston, MA, United States.
Indorica SutradharDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Jessica E AndersonDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Nourhan El SherifDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Muhammad H ZamanDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antimicrobial resistance (AMR) is a global health crisis that is predicted to worsen in the coming years. While improper antibiotic usage is an established driver, less is known about the impact of other endogenous and exogeneous environmental factors, such as metals, on AMR. One metal of interest is zinc as it is often used as a supplement for diarrhea treatment prior to antibiotics. Materials and methods: Here, we probed the impact of zinc on ciprofloxacin resistance in Results: Zinc pre-exposure led to a subsequent acceleration of ciprofloxacin resistance. Specifically, we saw that 5 days of zinc pre-exposure led samples to have nearly a 4× and 3× higher MIC after 2 and 3 days of subinhibitory antibiotics, respectively, compared to samples not pre-exposed to zinc, but only if ciprofloxacin exposure happened in the absence of zinc. Additionally, for samples that underwent the same pre-exposure treatment, those exposed to a combination of zinc and ciprofloxacin saw delayed ciprofloxacin resistance compared to those exposed to only ciprofloxacin resulting in up to a 5× lower MIC within the first 2 days of antibiotic exposure. We did not observe any genetic changes or changes in antibiotic tolerance in cells after zinc pre-exposure, suggesting changes in gene expression may underlie these phenotypes. Discussion: These results highlight the need to reexamine the role of zinc, and supplements more broadly, on antibiotic resistance evolution.

Indexed as

antimicrobial resistance (AMR)ciprofloxacin (CIP)conflict settingsenvironmental pollutionEscherichia coli (E. coli)zinc

Identifiers

PMID39717277
PMCPMC11663908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.